{"id":290895,"date":"2026-10-07T09:21:27","date_gmt":"2026-10-07T03:51:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=290895"},"modified":"2026-10-07T09:21:27","modified_gmt":"2026-10-07T03:51:27","slug":"niche-healthcare-service-stocks-strong-roadmap","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/","title":{"rendered":"3 Niche Healthcare Service Stocks With a Strong Future Roadmap: Thyrocare Technologies, Jeena Sikho Lifecare and Rainbow Children&#8217;s Medicare"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Thyrocare Rs 529.80, P\/E 47.96. Jeena Sikho Rs 441.25, P\/E 23.25. Rainbow Children&#8217;s Rs 1,239.70, P\/E 43.42. Closing prices of 6 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Niche healthcare service stocks with the clearest long-term roadmaps today include Thyrocare Technologies in diagnostic tests and health checkups through a large collection network, Jeena Sikho Lifecare in ayurveda hospitals and wellness centres and Rainbow Children&#8217;s Medicare in paediatric hospitals and maternity and fertility care. FY26 revenue growth was 20.5% at Thyrocare, 70.2% at Jeena Sikho and 11.5% at Rainbow Children&#8217;s. P\/E stands at 47.96 for Thyrocare (industry 62.73), 23.25 for Jeena Sikho (industry 37.19) and 43.42 for Rainbow Children&#8217;s (industry 62.73). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Niche healthcare service stocks give investors exposure to diagnostics, ayurveda care and paediatric hospitals. Results depend on patient volumes, test volumes and bed capacity, which is why occupancy and operating margin matter as much as headline growth.<\/p>\n<p>This list covers three healthcare provider stocks: Thyrocare Technologies for diagnostic tests and health checkups through a large collection network, Jeena Sikho Lifecare for ayurveda hospitals and wellness centres and Rainbow Children&#8217;s Medicare for paediatric hospitals and maternity and fertility care. Every figure comes from the latest reported financials and the 6 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=niche-healthcare-service-stocks-strong-roadmap\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#What_Are_Niche_Healthcare_Service_Stocks\" title=\"What Are Niche Healthcare Service Stocks?\">What Are Niche Healthcare Service Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Niche_Healthcare_Service_Stocks_at_a_Glance\" title=\"Niche Healthcare Service Stocks at a Glance\">Niche Healthcare Service Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Why_Do_Niche_Healthcare_Service_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Niche Healthcare Service Stocks Have a Strong Roadmap in India?\">Why Do Niche Healthcare Service Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Thyrocare_Technologies_Diagnostic_Tests_and_Health_Checkups_Anchor_the_Roadmap\" title=\"Thyrocare Technologies: Diagnostic Tests and Health Checkups Anchor the Roadmap\">Thyrocare Technologies: Diagnostic Tests and Health Checkups Anchor the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Jeena_Sikho_Lifecare_Ayurveda_Hospitals_and_New_Centres_Drive_the_Pipeline\" title=\"Jeena Sikho Lifecare: Ayurveda Hospitals and New Centres Drive the Pipeline\">Jeena Sikho Lifecare: Ayurveda Hospitals and New Centres Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Rainbow_Childrens_Medicare_Paediatric_Care_and_New_Hospitals_Build_the_Next_Leg\" title=\"Rainbow Children&#8217;s Medicare: Paediatric Care and New Hospitals Build the Next Leg\">Rainbow Children&#8217;s Medicare: Paediatric Care and New Hospitals Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Best_Niche_Healthcare_Service_Stocks_in_India_Thyrocare_vs_Jeena_Sikho_vs_Rainbow_Childrens_on_Key_Financials\" title=\"Best Niche Healthcare Service Stocks in India: Thyrocare vs Jeena Sikho vs Rainbow Children&#8217;s on Key Financials\">Best Niche Healthcare Service Stocks in India: Thyrocare vs Jeena Sikho vs Rainbow Children&#8217;s on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#How_to_Evaluate_Specialty_Hospital_and_Diagnostics_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Specialty Hospital and Diagnostics Stocks to Buy Before You Invest\">How to Evaluate Specialty Hospital and Diagnostics Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Risks_to_Consider_Before_Investing_in_Niche_Healthcare_Service_Stocks\" title=\"Risks to Consider Before Investing in Niche Healthcare Service Stocks\">Risks to Consider Before Investing in Niche Healthcare Service Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#FAQs_on_Niche_Healthcare_Service_Stocks\" title=\"FAQs on Niche Healthcare Service Stocks\">FAQs on Niche Healthcare Service Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Which_are_the_best_niche_healthcare_service_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best niche healthcare service stocks in India with a strong roadmap?\">Which are the best niche healthcare service stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Is_Thyrocare_Technologies_a_good_stock_to_buy_now\" title=\"Is Thyrocare Technologies a good stock to buy now?\">Is Thyrocare Technologies a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#What_is_the_PE_ratio_of_Thyrocare_Jeena_Sikho_and_Rainbow_Childrens\" title=\"What is the P\/E ratio of Thyrocare, Jeena Sikho and Rainbow Children&#8217;s?\">What is the P\/E ratio of Thyrocare, Jeena Sikho and Rainbow Children&#8217;s?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Which_of_these_niche_healthcare_service_stocks_has_the_highest_return_on_equity\" title=\"Which of these niche healthcare service stocks has the highest return on equity?\">Which of these niche healthcare service stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#What_are_the_risks_of_investing_in_niche_healthcare_service_stocks\" title=\"What are the risks of investing in niche healthcare service stocks?\">What are the risks of investing in niche healthcare service stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#How_did_Thyrocare_Jeena_Sikho_and_Rainbow_Childrens_perform_in_Q1_FY27\" title=\"How did Thyrocare, Jeena Sikho and Rainbow Children&#8217;s perform in Q1 FY27?\">How did Thyrocare, Jeena Sikho and Rainbow Children&#8217;s perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#Do_niche_healthcare_service_stocks_pay_dividends\" title=\"Do niche healthcare service stocks pay dividends?\">Do niche healthcare service stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/niche-healthcare-service-stocks-strong-roadmap\/#How_can_I_invest_in_niche_healthcare_service_stocks_in_India\" title=\"How can I invest in niche healthcare service stocks in India?\">How can I invest in niche healthcare service stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Niche_Healthcare_Service_Stocks\"><\/span><strong>What Are Niche Healthcare Service Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Niche healthcare service stocks are shares of companies that focus on one part of healthcare, such as diagnostic tests, ayurveda hospitals or paediatric care. Results depend on patient and test volumes, bed capacity, pricing and operating margin, so a focused brand and steady utilisation separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Niche_Healthcare_Service_Stocks_at_a_Glance\"><\/span><strong>Niche Healthcare Service Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three niche healthcare service stocks as of the 6 October 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/thyrocare\/thyrocare-technologies-ltd-share-price-today\">Thyrocare Technologies<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">529.80<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8,435<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">47.96<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.73<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.85%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.09<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/jsll\/jeena-sikho-lifecare-ltd-share-price-today\">Jeena Sikho Lifecare<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">441.25<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,495<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.25<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.19<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">47.50%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/rainbow\/rainbow-childrens-medicare-ltd-share-price-today\">Rainbow Children&#8217;s Medicare<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,239.70<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12,604<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">43.42<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.73<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.89%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.54<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare provider stocks, all three trade below their industry P\/E multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Niche_Healthcare_Service_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Niche Healthcare Service Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Niche healthcare service stocks have a strong roadmap in India because health awareness is rising, insurance cover is spreading and focused providers can build trusted brands. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Health awareness:<\/strong> More people take regular tests and seek specialised care.<\/li>\n<li><strong>Insurance cover:<\/strong> Wider cover brings more patients to private providers.<\/li>\n<li><strong>Focused brands:<\/strong> Specialists earn loyalty in a single care area.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Thyrocare_Technologies_Diagnostic_Tests_and_Health_Checkups_Anchor_the_Roadmap\"><\/span><strong>Thyrocare Technologies: Diagnostic Tests and Health Checkups Anchor the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Thyrocare&#8217;s roadmap rests on diagnostic tests and health checkups delivered through a large collection network, with a centralised lab model keeping costs low.<\/p>\n<p>Revenue grew from Rs 618.11 crore in FY22 to Rs 846.03 crore in FY26, a 36.9% rise, and FY26 revenue was 20.5% higher than FY25. FY26 net profit rose 79.4% to Rs 162.85 crore. Over four years, net profit moved from Rs 176.14 crore in FY22 to Rs 162.85 crore. In Q1 FY27, revenue grew 23.5% to Rs 244.17 crore, and net profit rose 34.1% to Rs 51.33 crore. Operating margin was 33.22% in FY26 and 34.22% in Q1 FY27 against 32.47% a year earlier.<\/p>\n<p>Debt to equity is 0.09 and return on equity is 27.85%. FY26 operating cash flow was Rs 213.23 crore against capital expenditure of Rs 20.88 crore. Thyrocare paid a dividend of Rs 14 per share for FY26, a yield of 2.64%. At a P\/E of 47.96 against an industry P\/E of 62.73, the stock trades below its industry multiple.<\/p>\n<p>What to watch: FY26 net profit of Rs 162.85 Cr is still below the Rs 176.14 Cr of FY22, and it paid a lower dividend for FY26 than for FY25.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jeena_Sikho_Lifecare_Ayurveda_Hospitals_and_New_Centres_Drive_the_Pipeline\"><\/span><strong>Jeena Sikho Lifecare: Ayurveda Hospitals and New Centres Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jeena Sikho&#8217;s roadmap rests on ayurveda hospitals and wellness centres, with new centres and rising patient volumes lifting revenue.<\/p>\n<p>Revenue grew from Rs 148.04 crore in FY22 to Rs 809.86 crore in FY26, a 447.1% rise, and FY26 revenue was 70.2% higher than FY25. FY26 net profit rose 177.3% to Rs 221.70 crore. Over four years, net profit rose from Rs 11.19 crore in FY22 to Rs 221.70 crore. In Q1 FY27, revenue grew 36.1% to Rs 238.73 crore, and net profit rose 28.5% to Rs 65.89 crore. Operating margin was 44.80% in FY26 and 47.41% in Q1 FY27 against 45.80% a year earlier.<\/p>\n<p>Debt to equity is 0.27 and return on equity is 47.50%. FY26 operating cash flow was Rs 253.75 crore against capital expenditure of Rs 34.05 crore. Jeena Sikho paid a dividend of Rs 4.5 per share for FY26, a yield of 1.02%. At a P\/E of 23.25 against an industry P\/E of 37.19, the stock trades below its industry multiple.<\/p>\n<p>What to watch: March 2026 quarter net profit of Rs 45.08 Cr was lower than the Rs 66.60 Cr of December 2025, and the model depends on steady patient inflow at new centres.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Rainbow_Childrens_Medicare_Paediatric_Care_and_New_Hospitals_Build_the_Next_Leg\"><\/span><strong>Rainbow Children&#8217;s Medicare: Paediatric Care and New Hospitals Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rainbow Children&#8217;s roadmap rests on paediatric hospitals and maternity and fertility care, with new hospitals and rising bed capacity supporting growth.<\/p>\n<p>Revenue grew from Rs 992.70 crore in FY22 to Rs 1,746.87 crore in FY26, a 76.0% rise, and FY26 revenue was 11.5% higher than FY25. FY26 net profit rose 15.3% to Rs 281.54 crore. Over four years, net profit rose from Rs 138.67 crore in FY22 to Rs 281.54 crore. In Q1 FY27, revenue grew 29.4% to Rs 482.70 crore, and net profit rose 16.2% to Rs 62.54 crore. Operating margin was 34.68% in FY26 and 31.35% in Q1 FY27 against 35.03% a year earlier.<\/p>\n<p>Debt to equity is 0.54 and return on equity is 16.89%. FY26 operating cash flow was Rs 419.66 crore against capital expenditure of Rs 216.46 crore. Rainbow Children&#8217;s paid a dividend of Rs 3.5 per share for FY26, a yield of 0.28%. At a P\/E of 43.42 against an industry P\/E of 62.73, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The Q1 FY27 operating margin of 31.35% was below the 35.03% of a year earlier as new hospitals ramp up.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Niche_Healthcare_Service_Stocks_in_India_Thyrocare_vs_Jeena_Sikho_vs_Rainbow_Childrens_on_Key_Financials\"><\/span><strong>Best Niche Healthcare Service Stocks in India: Thyrocare vs Jeena Sikho vs Rainbow Children&#8217;s on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best niche healthcare service stocks in India, Jeena Sikho leads on FY26 operating margin and Q1 FY27 revenue growth. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Thyrocare<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Jeena Sikho<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Rainbow Children&#8217;s<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">846.03<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">809.86<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,746.87<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">70.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Revenue growth FY22 to FY26<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">447.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">76.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">162.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">221.70<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">281.54<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">79.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">177.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.22%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">44.80%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 net profit growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.85%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">47.50%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">47.96<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.25<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">43.42<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.09<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.27<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.54<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.64%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.02%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">213.23<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">253.75<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">419.66<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare service earnings follow volumes and utilisation, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Specialty_Hospital_and_Diagnostics_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Specialty Hospital and Diagnostics Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen niche healthcare service stocks and shortlist specialty hospital and diagnostics stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by stock.<\/li>\n<li>Track operating margin across several quarters, because input costs can move faster than prices.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these niche healthcare service stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Niche_Healthcare_Service_Stocks\"><\/span><strong>Risks to Consider Before Investing in Niche Healthcare Service Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Utilisation:<\/strong> New hospitals and centres take time to fill, which can pull down margins.<\/li>\n<li><strong>Uneven profit:<\/strong> Thyrocare&#8217;s FY26 profit is still below its FY22 level.<\/li>\n<li><strong>Valuation:<\/strong> Thyrocare and Rainbow Children&#8217;s trade at more than 40 times earnings.<\/li>\n<li><strong>Regulation:<\/strong> Pricing and licensing rules can affect margins.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Thyrocare, Jeena Sikho and Rainbow Children&#8217;s live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three specialty hospital and diagnostics stocks cover diagnostic tests, ayurveda hospitals, and paediatric care. Jeena Sikho leads on FY26 operating margin and Q1 FY27 revenue growth.<\/p>\n<p>Across healthcare provider stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the specialty hospital and diagnostics stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Niche_Healthcare_Service_Stocks\"><\/span><strong>FAQs on Niche Healthcare Service Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_niche_healthcare_service_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best niche healthcare service stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies, Jeena Sikho Lifecare and Rainbow Children&#8217;s Medicare stand out for their roadmaps in diagnostics, ayurveda care and paediatric hospitals. FY26 revenue growth was 20.5% at Thyrocare, 70.2% at Jeena Sikho and 11.5% at Rainbow Children&#8217;s, and return on equity ranges from 16.89% to 47.50%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Thyrocare_Technologies_a_good_stock_to_buy_now\"><\/span><strong>Is Thyrocare Technologies a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies has a debt to equity ratio of 0.09, a return on equity of 27.85% and a P\/E of 47.96 against an industry P\/E of 62.73. Utilisation, uneven profit and valuation move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Thyrocare_Jeena_Sikho_and_Rainbow_Childrens\"><\/span><strong>What is the P\/E ratio of Thyrocare, Jeena Sikho and Rainbow Children&#8217;s?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 47.96 for Thyrocare (industry 62.73), 23.25 for Jeena Sikho (industry 37.19) and 43.42 for Rainbow Children&#8217;s (industry 62.73). All three trade below the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_niche_healthcare_service_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these niche healthcare service stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jeena Sikho Lifecare has the highest return on equity at 47.50%, followed by Thyrocare Technologies at 27.85% and Rainbow Children&#8217;s Medicare at 16.89%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_niche_healthcare_service_stocks\"><\/span><strong>What are the risks of investing in niche healthcare service stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are slow utilisation at new sites, uneven profit, high valuations and regulation. Thyrocare&#8217;s FY26 net profit is below its FY22 level, and Rainbow&#8217;s Q1 FY27 operating margin fell from a year earlier.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Thyrocare_Jeena_Sikho_and_Rainbow_Childrens_perform_in_Q1_FY27\"><\/span><strong>How did Thyrocare, Jeena Sikho and Rainbow Children&#8217;s perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies reported revenue of Rs 244.17 crore, up 23.5% year on year, and net profit rose 34.1% to Rs 51.33 crore. Jeena Sikho Lifecare reported revenue of Rs 238.73 crore, up 36.1% year on year, and net profit rose 28.5% to Rs 65.89 crore. Rainbow Children&#8217;s Medicare reported revenue of Rs 482.70 crore, up 29.4% year on year, and net profit rose 16.2% to Rs 62.54 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_niche_healthcare_service_stocks_pay_dividends\"><\/span><strong>Do niche healthcare service stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 2.64% for Thyrocare, 1.02% for Jeena Sikho and 0.28% for Rainbow Children&#8217;s, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_niche_healthcare_service_stocks_in_India\"><\/span><strong>How can I invest in niche healthcare service stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy niche healthcare service stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best niche healthcare service stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Thyrocare Technologies, Jeena Sikho Lifecare and Rainbow Children's Medicare stand out for their roadmaps in diagnostics, ayurveda care and paediatric hospitals. FY26 revenue growth was 20.5% at Thyrocare, 70.2% at Jeena Sikho and 11.5% at Rainbow Children's, and return on equity ranges from 16.89% to 47.50%.\"}},{\"@type\":\"Question\",\"name\":\"Is Thyrocare Technologies a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Thyrocare Technologies has a debt to equity ratio of 0.09, a return on equity of 27.85% and a P\/E of 47.96 against an industry P\/E of 62.73. Utilisation, uneven profit and valuation move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Thyrocare, Jeena Sikho and Rainbow Children's?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 47.96 for Thyrocare (industry 62.73), 23.25 for Jeena Sikho (industry 37.19) and 43.42 for Rainbow Children's (industry 62.73). All three trade below the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these niche healthcare service stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Jeena Sikho Lifecare has the highest return on equity at 47.50%, followed by Thyrocare Technologies at 27.85% and Rainbow Children's Medicare at 16.89%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in niche healthcare service stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are slow utilisation at new sites, uneven profit, high valuations and regulation. Thyrocare's FY26 net profit is below its FY22 level, and Rainbow's Q1 FY27 operating margin fell from a year earlier.\"}},{\"@type\":\"Question\",\"name\":\"How did Thyrocare, Jeena Sikho and Rainbow Children's perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Thyrocare Technologies reported revenue of Rs 244.17 crore, up 23.5% year on year, and net profit rose 34.1% to Rs 51.33 crore. Jeena Sikho Lifecare reported revenue of Rs 238.73 crore, up 36.1% year on year, and net profit rose 28.5% to Rs 65.89 crore. Rainbow Children's Medicare reported revenue of Rs 482.70 crore, up 29.4% year on year, and net profit rose 16.2% to Rs 62.54 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do niche healthcare service stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 2.64% for Thyrocare, 1.02% for Jeena Sikho and 0.28% for Rainbow Children's, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in niche healthcare service stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy niche healthcare service stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Thyrocare Technologies, Jeena Sikho Lifecare and Rainbow Children&#8217;s Medicare compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":28,"featured_media":290894,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[9127,9124,9128,9125,9126],"class_list":["post-290895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-jeena-sikho-lifecare","tag-niche-healthcare-service-stocks","tag-rainbow-childrens-medicare","tag-specialty-hospital-and-diagnostics-stocks","tag-thyrocare-technologies"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["290894"],"rank_math_title":["Niche Healthcare Service Stocks: Thyrocare, Jeena Sikho and More"],"rank_math_description":["Niche healthcare service stocks with a strong roadmap: Thyrocare, Jeena Sikho and Rainbow Children's compared on growth, margins, valuation and risks. Oct 2026 data."],"rank_math_focus_keyword":["niche healthcare service stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-niche-healthcare-service-stocks-with-a-strong-future-roadmap-thyrocare.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/290895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=290895"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/290895\/revisions"}],"predecessor-version":[{"id":290896,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/290895\/revisions\/290896"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/290894"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=290895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=290895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=290895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}